COLUMBUS, Ohio – Jeff A. Walker has been named the first executive director for The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
In this new role, Walker will oversee all administrative, operational and fiscal functions for Ohio State’s cancer program, which includes the James Cancer Hospital and Solove Research Institute, the first and only free-standing cancer hospital in Ohio, and The Ohio State University Comprehensive Cancer Center, with more than 270 researchers from 13 colleges at Ohio State.
Walker will guide the high-performance infrastructure necessary to support successful translational research so that scientific discoveries can be transformed into clinical care to reduce cancer incidence, morbidity, and mortality.
“Jeff’s experience in both free-standing and matrix cancer center environments will provide a unique perspective helpful in continuing along our strategic growth trajectory,” said Dr. Michael Caligiuri, director of The Ohio State University Comprehensive Cancer Center and CEO of the James Cancer Hospital and Solove Research Institute. “He will work closely with senior leadership and our top physicians and researchers to lead our journey toward becoming one of the top 10 cancer programs in the nation.”
With more than 10 years of previous administrative leadership experience at the University of Pittsburgh Cancer Institute, Walker was recruited and served from 2001 to 2007 as associate director of Ohio State’s Comprehensive Cancer Center.
Most recently, Walker has served as executive vice president for Roswell Park Cancer Research Institute in Buffalo, NY, where he has overseen the development, direction and operation of the Institute including the administrative, scientific and clinical departments, all mission area programs, strategic planning initiatives and the renewal of the National Cancer Institute core grant.
Walker earned his bachelor’s degree in biochemistry from Pennsylvania State University and a master’s degree in business administration from the University of Pittsburgh. He has served on the finance and investment committee of the Association of American Cancer Institutes, and is a member of the Alliance of Dedicated Cancer Centers, Cancer Center Administrators Forum and the Medical Group Management Association.
The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (https://cancer.osu.edu) is one of only 40 Comprehensive Cancer Centers in the United States designated by the National Cancer Institute. Ranked by U.S. News & World Report among the top 20 cancer hospitals in the nation, The James is the 180-bed adult patient-care component of the cancer program at The Ohio State University. The OSUCCC-James is one of only seven funded programs in the country approved by the NCI to conduct both Phase I and Phase II clinical trials.
# # #
Medical Center Communications